There's a letter coming to your parent's mailbox in September, and this is the year somebody in your family actually has to read it.
Here's why. On July 28, the Centers for Medicare and Medicaid Services announced it's ending the program that has been holding down premium increases on standalone Medicare drug plans. For the past two years, a plan that signed up for that program could not raise what it charged by more than a set amount from one year to the next. Starting January 1, that limit is gone. CMS put it in the language of policy people, saying the program will "return to operating under traditional market conditions." Translated into kitchen table English: whatever the plan wants to charge in 2027, it can charge.
If you're wondering why you haven't heard about this, it's because the announcement was written for insurance actuaries, not for the daughter who manages her mother's pill organizer. It came out as a technical bid memo on a Tuesday afternoon in the last week of July, which is roughly the least-read week of the year.
Eight years of buying houses from families in transition taught me something that has nothing to do with real estate: the thing that pushes a family into a bad decision is almost never one giant bill. It's the slow accumulation of small ones nobody planned for, until the only asset left to solve the problem with is the house. A drug plan premium going up more than anyone expected is exactly that kind of small bill.
You've got about ten weeks before the enrollment window opens. That's plenty of time, if you know what you're looking at.
What CMS actually announced
The program ending is called the Part D Premium Stabilization Demonstration. CMS created it in 2025, after the Inflation Reduction Act rewrote how Part D works, to keep premiums on standalone drug plans from swinging wildly while insurers figured out the new math.
According to CMS, the demonstration worked like this in its first year: a flat $15 reduction to the base beneficiary premium, a hard limit of $35 on how much a participating plan could raise its total Part D premium from the prior year, and narrowed risk corridors that shifted some of the insurer's losses onto the government. For 2026, CMS scaled it back: the flat reduction dropped from $15 to $10, the year-over-year increase limit rose from $35 to $50, and the narrowed risk corridors were eliminated entirely.
For 2027, there's nothing. CMS said its analysis of the bids insurers submitted showed that plan sponsors "had sufficient experience under the redesigned Part D benefit" to price without the backstop, so the demonstration ends when this year does.
The same July 28 announcement carried the underlying numbers. The national average monthly bid amount, which is the enrollment-weighted average of what insurers say it costs them to provide basic drug coverage, is $296.05 for 2027. Last year that figure was $239.27. The base beneficiary premium, which is the starting point for calculating what any individual plan charges, will be $41.33 in 2027, up from $38.99.
That $41.33 deserves a second look, because it's the one piece of good news in the announcement. CMS showed both halves of the calculation in its memo. The statutory formula produced $94.06. The Inflation Reduction Act caps the annual increase in the base premium at 6 percent, which produced $41.33. CMS is required to use the lesser of the two. So a provision most people have never heard of is currently absorbing more than fifty dollars a month of pressure on the underlying number.
Two other 2027 figures came out of the CMS rate announcement in April, and they're worth knowing now. The standard Part D deductible goes from $615 to $700. The annual out-of-pocket threshold, the point where a plan starts covering everything, goes from $2,100 to $2,400.
Who this actually hits
This is the part that gets reported wrong, so be precise about which situation your parent is in.
The demonstration only ever applied to standalone prescription drug plans. Those are the plans people buy alongside Original Medicare, usually because they want to keep seeing any doctor who takes Medicare and don't want a network telling them no. If your parent has Original Medicare plus a separate drug card, that's a standalone plan and this announcement is about them.
If your parent's drug coverage is built into a Medicare Advantage plan, the demonstration never covered them and nothing here changes directly.
The split is not small. CMS enrollment data for April 2026 shows 25.2 million people in standalone drug plans out of 70.3 million people on Medicare, with another 31.9 million getting drug coverage through a Medicare Advantage plan. So roughly one in three Medicare beneficiaries sits in the category that just lost a guardrail.
The 6 percent cap is not the protection you think it is
This trips up smart people, so slow down here. The Inflation Reduction Act's 6 percent cap applies to the base beneficiary premium, the national reference number. It does not cap what any particular plan charges you.
Your parent's actual premium is that base number adjusted by how their specific plan's bid compares to the national average, plus any supplemental premium for extra coverage, plus a late enrollment penalty if one applies. A plan can raise its own bid well past 6 percent even while the national base premium is capped. Until this year, the demonstration's dollar limit was the thing standing in the way of that. Now it isn't.
Worth noting for the long view: CMS confirmed in its 2027 rate announcement that commenters have already raised concerns about a "premium cliff" when the Inflation Reduction Act's premium stabilization provision expires after 2029. CMS declined to address it, saying it's outside the scope of this year's announcement. So the cap that's absorbing fifty-plus dollars a month right now has an expiration date on it too.
The January trap nobody warns families about
Here's the gap that costs families real money. If your parent picks the wrong drug plan this fall, they're generally stuck with it for the whole year.
Medicare's Open Enrollment runs October 15 to December 7, with the new coverage starting January 1. There's a second window, January 1 to March 31, and people assume it's a do-over. It isn't, not for this. Per Medicare, that January window only applies if your parent is already in a Medicare Advantage plan. It lets them switch Advantage plans or drop back to Original Medicare. Somebody on Original Medicare with a standalone drug plan gets no general opportunity to change drug plans in January.
That's why the fall matters more this year than last. The decision your family makes in November is the decision your parent lives with through next December.
What to do, in order
You don't need to become an expert on Part D. You need to do five specific things between now and December 7.
1. Find out which kind of coverage your parent actually has
Do this today, because everything else depends on it. Look at the insurance cards. One card that says Medicare Advantage or MAPD means the drug coverage is bundled. A red, white, and blue Medicare card plus a separate drug plan card means standalone, and this announcement is aimed at them. If the cards are confusing, the plan's member services number is on the back and they'll tell you in thirty seconds.
2. Open the September letter instead of filing it
Every Medicare plan is required to send an Annual Notice of Change each fall, and Medicare says it arrives in September. It spells out exactly what's changing in coverage, costs, and premium effective in January. Most families glance at it and set it on the counter. This year, find the premium line and the deductible line and write both numbers down next to what your parent pays now.
CMS releases the full 2027 plan landscape in mid-to-late September, so that letter and the public comparison data should land within a couple weeks of each other.
3. Run the comparison with the real drug list, not a guess
Medicare's Plan Finder at medicare.gov compares plans using your parent's actual prescriptions and their actual pharmacy. That last part matters more than people expect, because the same plan can price the same drug very differently depending on whether the pharmacy is in its preferred network.
Type in every medication, including the ones they've been on so long nobody thinks about them. The cheapest premium is frequently not the cheapest year, and you can't tell which is which without the real list.
4. Check whether Extra Help applies, even if you assume it doesn't
Extra Help is Medicare's low-income subsidy for Part D, and families skip it constantly because they assume the limits are lower than they are. For 2026, Medicare lists the qualifying limits as $23,940 in income and $18,090 in resources for an individual, and $32,460 in income and $36,100 in resources for a married couple.
If your parent qualifies, the difference isn't a discount. Medicare says Extra Help means a $0 plan premium, a $0 deductible, capped copays of up to $5.10 for a generic and $12.65 for a brand name, and $0 for covered drugs after total drug costs reach $2,100. It also waives the Part D late enrollment penalty.
You apply through Social Security, and your local State Health Insurance Assistance Program will help you fill it out for free. Applying costs nothing and being turned down costs nothing.
5. Whatever happens, don't let anyone drop drug coverage to save money
If the premium jumps and your parent's instinct is to cancel because they barely take anything, understand what that decision buys. Medicare's late enrollment penalty is 1 percent of the national base beneficiary premium times the number of full months they went without creditable coverage, and it's generally permanent for as long as they have Part D.
The penalty is also indexed to that base premium, which is going up. Two years uncovered adds about $9.40 a month at the 2026 base premium and about $9.90 at the 2027 one, every month, for the rest of their life. Dropping coverage to save forty dollars a month is one of the few Medicare mistakes you genuinely cannot undo.
Frequently Asked Questions
Will my parent's Medicare drug plan premium go up in 2027?
Nobody can tell you that yet, and be skeptical of anyone who claims otherwise. CMS has released the underlying bid figures but not what individual plans will charge. Those numbers come with the 2027 plan landscape in mid-to-late September and in the Annual Notice of Change your parent's plan mails that same month. What is known is that the $50 limit on year-over-year increases for participating standalone plans is gone for 2027.
What is the Part D Premium Stabilization Demonstration?
It was a voluntary CMS program for standalone Medicare drug plans, first run in 2025, created to smooth out premium swings while insurers adjusted to the Inflation Reduction Act's redesign of Part D. In 2026 it gave participating plans a $10 reduction to the base beneficiary premium and limited any plan's total Part D premium increase to $50 over the prior year. CMS announced on July 28, 2026 that it ends after this year.
Does this affect Medicare Advantage plans with drug coverage?
Not directly. The demonstration only applied to standalone prescription drug plans, the kind bought alongside Original Medicare. CMS data from April 2026 shows about 31.9 million people get drug coverage bundled into a Medicare Advantage plan and 25.2 million have a standalone plan. Compare options either way during Open Enrollment, since Advantage plans change their drug formularies and cost sharing every year too.
When can my parent switch Medicare drug plans?
Medicare's Open Enrollment runs October 15 through December 7, and the new plan starts January 1. The January 1 to March 31 window is not a second chance for drug plans: Medicare limits it to people already enrolled in a Medicare Advantage plan, who can switch Advantage plans or return to Original Medicare. Someone on Original Medicare with a standalone drug plan generally has no way to change it midyear.
How much is Medicare Part D going to cost out of pocket in 2027?
Per the CMS 2027 rate announcement, the standard deductible rises from $615 to $700, and the annual out-of-pocket threshold rises from $2,100 to $2,400. Once your parent's out-of-pocket spending hits that threshold, covered drugs cost nothing for the rest of the year. Those are the standard benefit parameters, and individual plans can differ, so check the specific plan's numbers.
About Ryan Riggins
Ryan Riggins is a senior transition advisor and former house flipper. After 8+ years buying homes from families in transition, he walked away from the cash-buyer side to help families avoid the $50K mistakes he used to profit from. Based in Greensboro, NC. NC Real Estate License #361546, eXp Realty. Founder of Riggins Strategic Solutions and the SeniorSafe app.
Not sure what Medicare leaves you paying for? The free Medicare Gap Analyzer walks through what's covered and what isn't: rigginsstrategicsolutions.com/tools/medicare-gap-analyzer
Want a step-by-step guide? The free Simple Blueprint walks through every stage of a senior transition: rigginsstrategicsolutions.com/freeguide
Ready for the full system? The Senior Transition Blueprint is free, all 20 modules and 69 tools: rigginsstrategicsolutions.com/the-blueprint
Need a personalized plan? The Senior Transition Roadmap is free, by application. It adds calls with Ryan and 90 days of email support: rigginsstrategicsolutions.com/blueprint-premium
Selling a parent's home? Ryan finds and vets the right local agent for your situation and stays in your corner on the whole sale, at no added cost to your family: rigginsstrategicsolutions.com/in-your-corner
Coordinate the family in one place. SeniorSafeApp keeps daily check-ins, medications, and documents where the whole family can see them: seniorsafeapp.com
Sources
All sources checked July 31, 2026.
CMS, "Medicare Part D 2027 National Average Monthly Bid Amount Information," fact sheet dated July 28, 2026 (cms.gov). End of the Part D Premium Stabilization Demonstration, the $296.05 bid amount, the $41.33 base beneficiary premium, the 6 percent cap, and the September landscape release.
CMS Center for Medicare and Office of the Actuary, "Annual Release of Part D National Average Monthly Bid Amount and Other Part C and D Bid Information," memoranda dated July 28, 2026 (cms.gov). Both halves of the base premium calculation, $41.33 capped against $94.06 statutory, and discontinuation at the end of CY 2026.
CMS, "2026 Medicare Part D Bid Information and Part D Premium Stabilization Demonstration Parameters," fact sheet dated July 28, 2025 (cms.gov). The 2025 parameters of $15, $35, and narrowed risk corridors; the 2026 parameters of $10, $50, and no narrowed corridors; the $239.27 and $38.99 figures for 2026.
CMS, "Announcement of Calendar Year 2027 Medicare Advantage Capitation Rates and Part C and Part D Payment Policies," Attachments IV and V (cms.gov). The 2027 deductible of $700 against $615, the out-of-pocket threshold of $2,400 against $2,100, and the CMS response on the premium cliff after 2029.
CMS Medicare Monthly Enrollment public dataset, April 2026 reporting month (data.cms.gov). 70,330,194 total beneficiaries, 25,227,591 in standalone drug plans, 31,898,844 in Medicare Advantage plans with drug coverage.
Medicare.gov, "When to join a Medicare health or drug plan," "Plan Annual Notice of Change," "Help with drug costs," and "Part D late enrollment penalty." Open Enrollment dates, the limits on the January window, September delivery of the Annual Notice of Change, the 2026 Extra Help limits and cost sharing, and the penalty formula.
Education, not advice. Plan premiums, formularies, and benefit figures change every year, and none of the 2027 plan-specific pricing is public yet. Confirm current details with the plan, with 1-800-MEDICARE, or with your free local State Health Insurance Assistance Program before you rely on them.
